Novartis AG will look for acquisitions in the range of $2 billion to $4 billion each in 2013, Bloomberg reported citing Joe Jimenez, Chief Executive Officer of Novartis. Novartis doesn't plan to sell its vaccines, animal health, and consumer health businesses, Bloomberg reported.